Michael Shetzline, SVP, CMO, Head-Res&Drug at IRONWOOD PHARMACEUTICALS INC (IRWD), sold 15,570 shares at $3.81 ($59K) on 2026-02-23, disclosed to the SEC on 2026-02-25.
Open-market sale of $59k IRWD by SVP, CMO, Head-Res&Drug. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| IRWD | SELL | 2024-02-14 | $1.2M | — | Filing → |
| IRWD | SELL | 2023-05-24 | $209K | — | Filing → |
| IRWD | SELL | 2023-03-01 | $385K | — | Filing → |